SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing intense community engagement and active institutional accumulation ahead of highly anticipated 52-week clinical trial data and upcoming investor conferences. Investors are closely tracking these catalysts as potential triggers for a long-awaited stock rerating, with significant discussion focused on the firm's competitive positioning within the inflammatory disease market.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors weigh Bitcoin's recent price volatility against ongoing institutional adoption and broader geopolitical uncertainties. Community discussions are heavily focused on navigating potential market pullbacks, debating the validity of treasury holdings in related crypto stocks, and speculating on how macroeconomic shifts like interest rate forecasts might impact future asset rotations.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as investors focus on its critical role in advanced semiconductor packaging and the anticipated growth of domestic chip infrastructure. The community is actively discussing the stock's long-term potential as a bottleneck-relieving partner for major semiconductor giants, while watching for technical strength amidst broader market volatility.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is currently in focus as investors analyze a massive rotation out of large-cap technology into small-cap value and cyclicals. The community is actively debating the sustainability of this price action amid shifting macroeconomic expectations, persistent inflationary pressures, and the potential impact of Federal Reserve policy decisions on small-cap liquidity.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings is trending as investors aggressively position for the AI infrastructure buildout, focusing on the critical bottleneck of data center power delivery and thermal management. The community is actively discussing the company's dominant role in liquid cooling solutions as hyperscale demand intensifies, fueling a bullish sentiment around its significant order backlog and capacity expansion.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market volatility as investors weigh the company's long-term potential in data-driven oncology against concerns over capital efficiency and insider selling. The stock remains a focal point for community debate, with bulls highlighting its expanding AI platform and high-profile partnerships, while bears emphasize high short interest and questions surrounding long-term profitability.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently a battleground for investors as it trades near multi-year lows, sparking intense debate between those viewing it as a deep-value accumulation opportunity due to its real-world institutional adoption and those concerned about its prolonged market underperformance. While the community remains polarized over the technical resilience of the network, many are actively tracking potential regulatory catalysts and institutional inflow to determine if the asset is entering a base-building phase or remains a long-term value trap.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp is trending as investors reassess its essential role in the semiconductor ecosystem, weighing its near-monopoly in process control and yield management against broader volatility in wafer fab equipment spending. The community is actively debating the company's valuation in the context of long-term AI infrastructure build-out and how it compares to equipment peers amidst fluctuating demand for advanced manufacturing nodes.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is drawing significant investor interest as the market closely monitors upcoming Phase 3 clinical data for its mental health treatment programs. The community is actively debating the stock's potential for a breakthrough while weighing the company's cash runway and the broader risks inherent in the biotech sector.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The Vanguard S&P 500 ETF is trending as investors weigh strong corporate earnings and AI-driven growth against ongoing geopolitical uncertainty and recent hawkish signals from the Federal Reserve. Community discussion remains heavily polarized between proponents of long-term passive index investing and those concerned about market breadth and potential volatility linked to global conflicts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kingstone Companies (KINS) Expected to Announce Quarterly Earnings on Thursday

Kingstone Companies (NASDAQ:KINS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Insider Selling: Kingstone Companies (NASDAQ:KINS) Director Sells 13,500 Shares of Stock

Kingstone Companies, Inc (NASDAQ:KINS - Get Free Report) Director William Yankus sold 13,500 shares of the business's stock in a transaction on Thursday, April 16th. The shares were sold at an...

Kingstone Companies (NASDAQ:KINS) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen raised Kingstone Companies from a "hold" rating to a "buy" rating in a research note on Saturday...

Kingstone Companies (NASDAQ:KINS) Director William Yankus Sells 13,500 Shares

Kingstone Companies, Inc (NASDAQ:KINS - Get Free Report) Director William Yankus sold 13,500 shares of the stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $18.00, for a total value of $243,000.00. Following the transaction, the director directly owned...

Kingstone Companies (NASDAQ:KINS) Share Price Passes Above 50-Day Moving Average   - Should You Sell?

Kingstone Companies (NASDAQ:KINS) Stock Passes Above Fifty Day Moving Average - Time to Sell...

Kingstone Companies (NASDAQ:KINS) Stock Crosses Below 200 Day Moving Average - Should You Sell?

Kingstone Companies (NASDAQ:KINS) Shares Pass Below Two Hundred Day Moving Average - Here's What Happened...

Kingstone Companies (NASDAQ:KINS) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Kingstone Companies from a "buy" rating to a "hold" rating in a research report on Saturday...

Kingstone Companies Q4 Earnings Call Highlights

Kingstone Companies (NASDAQ:KINS) used its fourth-quarter earnings call to highlight what management described as the most profitable quarter and full year in the insurer's history, driven by strong...

Kingstone Companies (NASDAQ:KINS) Releases FY 2026 Earnings Guidance

Kingstone Companies (NASDAQ:KINS) updated its FY 2026 earnings guidance. The company provided EPS guidance of 2.200-2.900 for the period, compared to the consensus estimate of 2.500...

Kingstone Companies (NASDAQ:KINS) Releases Earnings Results, Beats Estimates By $0.02 EPS

Kingstone Companies (NASDAQ:KINS - Get Free Report) released its quarterly earnings results on Thursday. The insurance provider reported $1.08 EPS for the quarter, beating analysts' consensus...

Kindred Biosciences is a veterinary biotechnology company, focuses on developing therapies for dogs, cats, and horses. It develops canine, feline, and equine antibodies for the treatment of diseases in companion animals. Its strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. Their mission is to bring innovative biologics to veterinary medicine because they believe their pets deserve the same kinds of safe and effective medicines that human family members enjoy. The company was incorporated in 2012 and is based in San Francisco, California.

Kindred Biosciences Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$9.25
Prev Close	$9.24
Open	$9.25
Dividend Yield	N/A
50-Day Moving Average	$9.19
Beta	1.17
Avg. Volume	805,918.62
PE Ratio	-9.02

52-Week High	$9.28
52-Week Low	$3.46
Market Capitalization	$420.53M
EPS (Annual)	N/A
Price to Book	5.27
Revenue Per Employee	N/A

KINKindred Biosciences Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest KIN News